sRNAlytics  is at the forefront of small RNA research. We offer technology and services to drug developers to facilitate therapeutic development by providing deep analysis of disease pathways within a drug’s mechanism of action. Our analytical approach and wet-lab protocols, combined with sRNA-FIND and a growing database of over 15,000 patient samples, is focused on accelerating our partners programs.

World Class Team

David W. Salzman, PhD
Founder and CEO

Alan P. Salzman, PhD
COO

Scientific Advisory Board

Frank J. Slack, PhD
Harvard Medical School

Richard H. Myers, PhD
BU Medical School

Joanne B. Weidhaas, MD, PhD
UCLA Medical School

Melanie L. Leitner, PhD
Accelerating Neuro

Legal Advisors

There is a pervasive need to create new medicines for the treatment of diseases, which drives scientific breakthroughs and advances technology.
Combining new types of data, algorithms and computing platforms empowers sRNAlytics to create, and invent.
Join us in our mission to solve meaningful problems and make the world a better place.